Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV- 2 variants delta and omicron - results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP)
Abstract <jats:underline>Purpose</jats:underline> The influence of new SARS-CoV-2 variants on the post-COVID-19 condition (PCC) remains unanswered. Therefore, we examined the prevalence and predictors of PCC-related symptoms in patients infected with the SARS-CoV-2 variants delta or omicron. <jats:underline>Methods</jats:underline> We compared prevalences and risk factors of acute and PCC-related symptoms three months after primary infection (3MFU) between delta- and omicron-infected patients from the Cross-Sectoral Platform of the German National Pandemic Cohort Network. Health-related quality of life (HrQoL) was determined by the EQ-5D-5L index score and trend groups were calculated to describe changes of HrQoL between different time points. <jats:underline>Results</jats:underline> We considered 758 patients for our analysis (delta: n = 341; omicron: n = 417). Compared with omicron patients, delta patients had a similar prevalence of PCC at the 3MFU (p = 0.354), whereby fatigue occurred most frequently (n = 256, 34%). HrQoL was comparable between the groups with the lowest EQ-5D-5L index score (0.75, 95%-CI 0.73-0.78) at disease onset. While most patients (69%, n = 348) never showed a declined HrQoL, it deteriorated substantially in 37 patients (7%) from the acute phase to the 3MFU of which 27 were infected with omicron. <jats:underline>Conclusion</jats:underline> With quality-controlled data from a multicenter cohort, we showed that PCC is an equally common challenge for patients infected with the SARS-CoV-2 variants delta and omicron at least for the German population. Developing the EQ-5D-5L index score trend groups showed that over two thirds of patients did not experience any restrictions in their HrQoL due to or after the SARS-CoV-2 infection at the 3MFU. The cohort is registered at ClinicalTrials.gov since February 24, 2021 (Identifier: NCT04768998)..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
ResearchSquare.com - (2024) vom: 10. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.21203/rs.3.rs-3845618/v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XRA042130379 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | XRA042130379 | ||
| 003 | DE-627 | ||
| 005 | 20240111130947.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240111s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21203/rs.3.rs-3845618/v1 |2 doi | |
| 035 | |a (DE-627)XRA042130379 | ||
| 035 | |a (ResearchSquare)10.21203/rs.3.rs-3845618/v1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hopff, Sina M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV- 2 variants delta and omicron - results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract <jats:underline>Purpose</jats:underline> The influence of new SARS-CoV-2 variants on the post-COVID-19 condition (PCC) remains unanswered. Therefore, we examined the prevalence and predictors of PCC-related symptoms in patients infected with the SARS-CoV-2 variants delta or omicron. <jats:underline>Methods</jats:underline> We compared prevalences and risk factors of acute and PCC-related symptoms three months after primary infection (3MFU) between delta- and omicron-infected patients from the Cross-Sectoral Platform of the German National Pandemic Cohort Network. Health-related quality of life (HrQoL) was determined by the EQ-5D-5L index score and trend groups were calculated to describe changes of HrQoL between different time points. <jats:underline>Results</jats:underline> We considered 758 patients for our analysis (delta: n = 341; omicron: n = 417). Compared with omicron patients, delta patients had a similar prevalence of PCC at the 3MFU (p = 0.354), whereby fatigue occurred most frequently (n = 256, 34%). HrQoL was comparable between the groups with the lowest EQ-5D-5L index score (0.75, 95%-CI 0.73-0.78) at disease onset. While most patients (69%, n = 348) never showed a declined HrQoL, it deteriorated substantially in 37 patients (7%) from the acute phase to the 3MFU of which 27 were infected with omicron. <jats:underline>Conclusion</jats:underline> With quality-controlled data from a multicenter cohort, we showed that PCC is an equally common challenge for patients infected with the SARS-CoV-2 variants delta and omicron at least for the German population. Developing the EQ-5D-5L index score trend groups showed that over two thirds of patients did not experience any restrictions in their HrQoL due to or after the SARS-CoV-2 infection at the 3MFU. The cohort is registered at ClinicalTrials.gov since February 24, 2021 (Identifier: NCT04768998). | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Appel, Katharina S. |4 aut | |
| 700 | 1 | |a Miljukov, Olga |4 aut | |
| 700 | 1 | |a Schneider, Johannes |4 aut | |
| 700 | 1 | |a Addo, Marylyn M. |4 aut | |
| 700 | 1 | |a Bals, Robert |4 aut | |
| 700 | 1 | |a Bercker, Sven |4 aut | |
| 700 | 1 | |a Blaschke, Sabine |4 aut | |
| 700 | 1 | |a Bröhl, Isabel |4 aut | |
| 700 | 1 | |a Büchner, Nikolaus |4 aut | |
| 700 | 1 | |a Dashti, Hiwa |4 aut | |
| 700 | 1 | |a Erber, Johanna |4 aut | |
| 700 | 1 | |a Friedrichs, Anette |4 aut | |
| 700 | 1 | |a Geisler, Ramsia |4 aut | |
| 700 | 1 | |a Göpel, Siri |4 aut | |
| 700 | 1 | |a Hagen, Marina |4 aut | |
| 700 | 1 | |a Hanses, Frank |4 aut | |
| 700 | 1 | |a Jensen, Björn-Erik Ole |4 aut | |
| 700 | 1 | |a Keul, Maria |4 aut | |
| 700 | 1 | |a Krawczyk, Adalbert |4 aut | |
| 700 | 1 | |a Lorenz-Depiereux, Bettina |4 aut | |
| 700 | 1 | |a Meybohm, Patrick |4 aut | |
| 700 | 1 | |a Milovanovic, Milena |4 aut | |
| 700 | 1 | |a Mitrov, Lazar |4 aut | |
| 700 | 1 | |a Nürnberger, Carolin |4 aut | |
| 700 | 1 | |a Obst, Wilfried |4 aut | |
| 700 | 1 | |a Römmele, Christoph |4 aut | |
| 700 | 1 | |a Schäfer, Christian |4 aut | |
| 700 | 1 | |a Scheer, Christian |4 aut | |
| 700 | 1 | |a Scherer, Margarete |4 aut | |
| 700 | 1 | |a Schmidt, Julia |4 aut | |
| 700 | 1 | |a Seibel, Kristina |4 aut | |
| 700 | 1 | |a Sikdar, Shimita |4 aut | |
| 700 | 1 | |a Tebbe, Johannes Josef |4 aut | |
| 700 | 1 | |a Tepasse, Phil-Robin |4 aut | |
| 700 | 1 | |a Thelen, Philipp |4 aut | |
| 700 | 1 | |a Vehreschild, Maria J.G.T. |4 aut | |
| 700 | 1 | |a Weismantel, Christina |4 aut | |
| 700 | 1 | |a Vehreschild, J. Janne |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2024) vom: 10. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:10 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-3845618/v1 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XRA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 10 |c 01 | ||